Coastal Infusion Administers Tremfya^®

Tremfya (guselkumab) is used to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis.

The active substance in Tremfya, guselkumab, is an antibody designed to attach to interleukin-23 (IL-23) and block its activity. IL-23 is a protein that controls the growth and maturation of some types of T cells. These T cells are involved in causing inflammation that is linked to the development of ulcerative colitis. By blocking the action of IL-23, Tremfya reduces inflammation and symptoms associated with the disease.

What It Treats

• Plaque psoriasis
• Psoriatic arthritis

Prescribed By

Tremfya is most often prescribed by Rheumatologists and Dermatologists.

How it's Administered

Tremfya is administered by subcutaneous injection. Tremfya injections take only a few minutes.

Frequency

Tremfya injections are administered every eight weeks after two starter doses, four weeks apart.

Related Drugs

Ilumya, Omvoh, Skyrizi, Stelara

Additional Resources

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies